Neurodegeneration in Alzheimer's disease (AD) is likely associated with disrupted brain glucose metabolism, a well-documented metabolic abnormality that precedes the disease and appears to be influenced by dysfunctional insulin signaling in the AD brain. Here, INS is linked to Alzheimer disease.